HIF-1alpha Induced-VEGF Overexpression in Bone Marrow Stem Cells Protects Cardiomyocytes Against Ischemia

Overview

Journal J Mol Cell Cardiol

Specialty Cardiology & Vascular Diseases

Date 2007 May 15

PMID 17498737

Citations 77

Authors

Ying Dai

Meifeng Xu

Yigang Wang

Zeeshan Pasha

Tingyu Li

Muhammad Ashraf

Affiliations

Soon will be listed here.

Abstract

Hypoxia inducible factor-1alpha (HIF-1alpha) is a proangiogenic transcription factor stabilized and activated under hypoxia. It regulates the expression of numerous target genes, including vascular endothelial growth factor (VEGF) and other cytoprotective proteins. In this study, we hypothesized that bone marrow stem cells (BMSCs) secrete growth factors which protect cardiomyocytes via HIF-1alpha pathway. BMSCs were obtained from transgenic mice overexpressing green fluorescent protein (GFP). The study was carried out in vitro using co-culture of BMSCs with cardiomyocytes. LDH release, MTT uptake, DNA fragmentation and annexin-V positive cells were used as cell injury markers. The level of HIF-1alpha protein as well as its activated form and VEGF were measured by ELISA. The expression of HIF-1alpha and VEGF in BMSCs was analyzed by quantitative PCR and cellular localization was determined by immunohistochemistry. LDH release was increased and MTT uptake was decreased after exposure of cardiomyocytes to hypoxia for 30 h, which were prevented by co-culturing cardiomyocytes with BMSCs. Cardiomyocyte apoptosis induced by hypoxia and H(2)O(2) was also reduced by co-culture with BMSCs. VEGF release from BMSCs was significantly increased in parallel with high level of HIF-1alpha in BMSCs following anoxia or hypoxia in a time-dependent manner. Although no significant up-regulation could be seen in HIF-1alpha mRNA, HIF-1alpha protein and its activated form were markedly increased and translocated to the nucleus or peri-nuclear area. The increase and translocation of HIF-1alpha in BMSCs were completely blocked by 2-methoxyestradiol (2-ME2; 5 mumol), a HIF-1alpha inhibitor. Moreover, the protection of cardiomyocytes by BMSC and VEGF secretion was abolished by neutralizing HIF-1alpha antibody in a concentration dependent manner (200-3200 ng/ml). Bone marrow stem cells protect cardiomyocytes by up-regulation of VEGF via activating HIF-1alpha.

Citing Articles

Gene Therapy for Cardiovascular Disease: Clinical Perspectives.

Lee Y, Choi J, Kim J Yonsei Med J. 2024; 65(10):557-571.

PMID: 39313446 PMC: 11427124. DOI: 10.3349/ymj.2024.0127.

Role of HIF-1α-Activated IL-22/IL-22R1/Bmi1 Signaling Modulates the Self-Renewal of Cardiac Stem Cells in Acute Myocardial Ischemia.

Lee W, Lin S, Chiang C, Chen J, Chieng W, Huang S Stem Cell Rev Rep. 2024; 20(8):2194-2214.

PMID: 39264501 PMC: 11554697. DOI: 10.1007/s12015-024-10774-8.

Role of macrophage polarization in heart failure and traditional Chinese medicine treatment.

Zhu Z, Wang M, Lu S, Dai S, Liu J Front Pharmacol. 2024; 15:1434654.

PMID: 39104386 PMC: 11298811. DOI: 10.3389/fphar.2024.1434654.

Crosstalk between DNA methylation and hypoxia in acute myeloid leukaemia.

Humphries S, Bond D, Germon Z, Keely S, Enjeti A, Dun M Clin Epigenetics. 2023; 15(1):150.

PMID: 37705055 PMC: 10500762. DOI: 10.1186/s13148-023-01566-x.

Mesenchymal Stem Cell in Pancreatic Islet Transplantation.

Barachini S, Biso L, Kolachalam S, Petrini I, Maggio R, Scarselli M Biomedicines. 2023; 11(5).

PMID: 37239097 PMC: 10216083. DOI: 10.3390/biomedicines11051426.

References

Xu M, Wang Y, Hirai K, Ayub A, Ashraf M . Calcium preconditioning inhibits mitochondrial permeability transition and apoptosis. Am J Physiol Heart Circ Physiol. 2001; 280(2):H899-908. DOI: 10.1152/ajpheart.2001.280.2.H899. View

Xu M, Uemura R, Dai Y, Wang Y, Pasha Z, Ashraf M . In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function. J Mol Cell Cardiol. 2006; 42(2):441-8. PMC: 1899533. DOI: 10.1016/j.yjmcc.2006.10.009. View

Kitta K, Day R, Ikeda T, Suzuki Y . Hepatocyte growth factor protects cardiac myocytes against oxidative stress-induced apoptosis. Free Radic Biol Med. 2001; 31(7):902-10. DOI: 10.1016/s0891-5849(01)00663-3. View

Brahimi-Horn C, Berra E, Pouyssegur J . Hypoxia: the tumor's gateway to progression along the angiogenic pathway. Trends Cell Biol. 2001; 11(11):S32-6. DOI: 10.1016/s0962-8924(01)02126-2. View

Tacchini L, Fusar-Poli D, Bernelli-Zazzera A . Activation of transcription factors by drugs inducing oxidative stress in rat liver. Biochem Pharmacol. 2002; 63(2):139-48. DOI: 10.1016/s0006-2952(01)00836-x. View

Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L . G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol. 2002; 3(7):687-94. DOI: 10.1038/ni813. View

Wenger R . Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J. 2002; 16(10):1151-62. DOI: 10.1096/fj.01-0944rev. View

Semenza G . Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol. 2002; 64(5-6):993-8. DOI: 10.1016/s0006-2952(02)01168-1. View

Kawamoto A, Tkebuchava T, Yamaguchi J, Nishimura H, Yoon Y, Milliken C . Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation. 2003; 107(3):461-8. DOI: 10.1161/01.cir.0000046450.89986.50. View

10.

Badorff C, Brandes R, Popp R, Rupp S, Urbich C, Aicher A . Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation. 2003; 107(7):1024-32. DOI: 10.1161/01.cir.0000051460.85800.bb. View

11.

Mabjeesh N, Escuin D, LaVallee T, Pribluda V, Swartz G, Johnson M . 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell. 2003; 3(4):363-75. DOI: 10.1016/s1535-6108(03)00077-1. View

12.

Pugh C, Ratcliffe P . Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med. 2003; 9(6):677-84. DOI: 10.1038/nm0603-677. View

13.

Bittira B, Shum-Tim D, Al-Khaldi A, Chiu R . Mobilization and homing of bone marrow stromal cells in myocardial infarction. Eur J Cardiothorac Surg. 2003; 24(3):393-8. DOI: 10.1016/s1010-7940(03)00325-7. View

14.

Tang Y, Zhao Q, Zhang Y, Cheng L, Liu M, Shi J . Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Regul Pept. 2003; 117(1):3-10. DOI: 10.1016/j.regpep.2003.09.005. View

15.

Torella D, Rota M, Nurzynska D, Musso E, Monsen A, Shiraishi I . Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res. 2004; 94(4):514-24. DOI: 10.1161/01.RES.0000117306.10142.50. View

16.

Xu H, Li G, Jiang H, Wang J, Lu J, Jiang W . Implantation of BM cells transfected with phVEGF165 enhances functional improvement of the infarcted heart. Cytotherapy. 2004; 6(3):204-11. DOI: 10.1080/14653240410006013. View

17.

Hagen T, DAmico G, Quintero M, Palacios-Callender M, Hollis V, Lam F . Inhibition of mitochondrial respiration by the anticancer agent 2-methoxyestradiol. Biochem Biophys Res Commun. 2004; 322(3):923-9. DOI: 10.1016/j.bbrc.2004.07.204. View

18.

Xu M, Wani M, Dai Y, Wang J, Yan M, Ayub A . Differentiation of bone marrow stromal cells into the cardiac phenotype requires intercellular communication with myocytes. Circulation. 2004; 110(17):2658-65. DOI: 10.1161/01.CIR.0000145609.20435.36. View

19.

Wang G, Jiang B, Rue E, Semenza G . Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A. 1995; 92(12):5510-4. PMC: 41725. DOI: 10.1073/pnas.92.12.5510. View

20.

Forsythe J, Jiang B, Iyer N, Agani F, Leung S, Koos R . Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol. 1996; 16(9):4604-13. PMC: 231459. DOI: 10.1128/MCB.16.9.4604. View